IMPCL Ties Up With Government E-Market Portal To Sell Its Products Online

Mumbai : The Indian Medicines Pharmaceutical Corporation Limited (IMPCL), the public sector manufacturing unit of the Union Ministry of Ayush, has tied up with the government e-market (GeM) portal for selling its products online.

The deal between IMPCL and GeM was finalised on March 03, 2021 when GeM created 31 categories covering 311 medicines, which are live in the marketplace and IMPCL can now upload these medicines on GeM portal, said the statement issued by the Union Ministry of Ayush.

IMPCL, the Rs. 100 crore turnovers PSU of the Union Ministry of Ayush, is one of the most trusted manufacturers of Ayush medicines in the country, and is known for the authenticity of its formulations. Following the tie-up, ayurvedic and Unani medicines of IMPCL will figure on the GeM portal to hundreds of government sector buyers at prices finalised by the Union ministry of finance, it further stated.

This will facilitate quick procurement of these medicines by Central/state government institutions for their healthcare programmes. Thus, this tie-up between GeM & IMPCL also helps to streamline the procurement and distribution of ayurvedic and Unani medicines by state units.

The thousands of patients and other clients who visit government Ayush hospitals every day stand to gain because of this increased availability of such medicines even in far-flung Ayush hospitals and clinics.

The Central government has approved 12,500 Ayush health and wellness centres to be operationalized by Union Ministry of Ayush through State/UT governments under Centrally Sponsored Scheme of National Ayush Mission (NAM) in a phased manner by the year 2023-24. It is envisaged to upgrade Ayush dispensaries and sub-health centres identified by state/UT governments as Ayush health and wellness centres for providing Ayush based preventive, primitive, curative and rehabilitative care.

  • Related Posts

    • Pharma
    • July 24, 2025
    • 81 views
    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

    • Pharma
    • July 22, 2025
    • 177 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra